Open AccessA Prospective Randomised Open Label Study to Evaluate the Response Rate and Toxicity of Gefitinib in the Treatment of Carcinoma Cervix Patients on Chemoradiotherapy
Author(s) -
Sowmya MS,
Manjunath Manjunath,
Basavanna PL,
Ramya KN,
Mukesh Mukesh
Publication year - 2022
Publication title -
journal of clinical research and applied medicine
Language(s) - English
Resource type - Journals
ISSN - 2583-0562
DOI - 10.5530/jcram.1.2.14
Subject(s) - gefitinib , medicine , cervical cancer , oncology , chemoradiotherapy , cisplatin , cervix , chemotherapy , adverse effect , epidermal growth factor receptor , cancer , prospective cohort study , radiation therapy , toxicity